Sg3 Management, LLC Rubius Therapeutics, Inc. Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.79 - $5.98 $32,548 - $246,376
-41,200 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.25 - $10.4 $175,100 - $428,480
41,200 New
41,200 $227,000
Q4 2021

Feb 15, 2022
SELL
$9.68 - $17.74 $290,400 - $532,200
-30,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$17.6 - $25.91 $528,000 - $777,300
30,000 New
30,000 $536,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email